Retrospective Cohort Study
Copyright ©The Author(s) 2025.
World J Hepatol. Mar 27, 2025; 17(3): 103261
Published online Mar 27, 2025. doi: 10.4254/wjh.v17.i3.103261
Table 5 Univariate and multivariate Cox regression analyses for liver failure before and after propensity score matching
Characteristics
Before PSM, univariate analyses (n = 815)
Before PSM, multivariate analyses (n = 815)
After PSM, univariate analyses (n = 662)
After PSM, univariate analyses (n = 662)
HR
95%CI
P
HR
95%CI
P
HR
95%CI
P
HR
95%CI
P
Group B2.1661.288-3.6430.004b2.5231.486-4.2830.001b2.2381.284-3.9010.005b2.2411.276-3.9370.005b
Creatinine2.8021.536-5.1100.001b3.0961.702-5.630< 0.001b2.5291.287-4.9700.007b3.121.500-6.4860.002b
Right hepatic venous wedge pressure2.6141.223-5.5860.013a2.6431.229-5.6800.013a1.9410.858-4.3920.112
Alanine aminotransferase1.450.979-2.1460.0641.6831.091-2.5980.019a1.5411.003-2.3660.048a
Cancer antigen 1530.7270.484-1.0920.1240.8140.511-1.2990.389
Platelet count1.2650.893-1.7940.1861.2610.855-1.8590.242
Carcinoembryonic antigen0.8770.639-1.2020.4140.8520.597-1.2180.38
C-Reactive protein1.1661.049-1.2960.004b1.1381.022-1.2670.019a
Alkaline phosphatase1.4610.909-2.3480.117
Pre-TIPS right atrial pressure1.5950.882-2.8840.123
International normalized ratio0.2830.044-1.8450.187
Blood ammonia0.7040.440-1.1290.145
Pre-TIPS MELD score0.60.024-14.8840.755
Activated partial thromboplastin time2.9520.880-9.9050.08
Hemoglobin2.5510.903-7.2050.077